BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 10647923)

  • 1. Protection of mice against soman by pretreatment with eptastigmine and physostigmine.
    Tuovinen K; Hänninen O
    Toxicology; 1999 Dec; 139(3):233-41. PubMed ID: 10647923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Function of plasma and microsomal enzymes in soman toxicity.
    Tuovinen K
    Drug Chem Toxicol; 2004 Feb; 27(1):69-75. PubMed ID: 15038249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Success of pyridostigmine, physostigmine, eptastigmine and phosphotriesterase treatments in acute sarin intoxication.
    Tuovinen K; Kaliste-Korhonen E; Raushel FM; Hänninen O
    Toxicology; 1999 Jun; 134(2-3):169-78. PubMed ID: 10403635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physostigmine (alone and together with adjunct) pretreatment against soman, sarin, tabun and VX intoxication.
    Harris LW; Talbot BG; Lennox WJ; Anderson DR; Solana RP
    Drug Chem Toxicol; 1991; 14(3):265-81. PubMed ID: 1935706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eptastigmine: ten years of pharmacology, toxicology, pharmacokinetic, and clinical studies.
    Braida D; Sala M
    CNS Drug Rev; 2001; 7(4):369-86. PubMed ID: 11830755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subchronic physostigmine pretreatment in marmosets: absence of side effects and effectiveness against soman poisoning with negligible postintoxication incapacitation.
    Philippens IH; Vanwersch RA; Groen B; Olivier B; Bruijnzeel PL; Melchers BP
    Toxicol Sci; 2000 Jan; 53(1):84-91. PubMed ID: 10653525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Organophosphate-induced convulsions and prevention of neuropathological damages.
    Tuovinen K
    Toxicology; 2004 Mar; 196(1-2):31-9. PubMed ID: 15036754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphotriesterase, pralidoxime-2-chloride (2-PAM) and eptastigmine treatments and their combinations in DFP intoxication.
    Tuovinen K; Kaliste-Korhonen E; Raushel FM; Hänninen O
    Toxicol Appl Pharmacol; 1996 Dec; 141(2):555-60. PubMed ID: 8975781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of subacute pretreatment with carbamate together with acute adjunct pretreatment against nerve agent exposure.
    Anderson DR; Harris LW; Lennox WJ; Solana RP
    Drug Chem Toxicol; 1991; 14(1-2):1-19. PubMed ID: 1889370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minimum effective drug concentrations of a transdermal patch system containing procyclidine and physostigmine for prophylaxis against soman poisoning in rhesus monkeys.
    Cho Y; Kim WS; Hur GH; Ha YC
    Environ Toxicol Pharmacol; 2012 Jan; 33(1):1-8. PubMed ID: 22051905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection by a transdermal patch containing physostigmine and procyclidine of soman poisoning in dogs.
    Kim WS; Cho Y; Kim JC; Huang ZZ; Park SH; Choi EK; Shin S; Nam SY; Kang JK; Hwang SY; Kim YB
    Eur J Pharmacol; 2005 Nov; 525(1-3):135-42. PubMed ID: 16256978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subchronic administration of various pretreatments of nerve agent poisoning. II. Compared efficacy against soman toxicity.
    Lallement G; Foquin A; Dorandeu F; Baubichon D; Carpentier P
    Drug Chem Toxicol; 2001 May; 24(2):165-80. PubMed ID: 11360433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection of guinea pigs against soman poisoning with ferrocene carbamate.
    Karlsson N; Larsson R; Puu G
    Arch Toxicol; 1992; 66(9):629-32. PubMed ID: 1482285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eptastigmine-phosphotriesterase combination in DFP intoxication.
    Tuovinen K; Kaliste-Korhonen E; Raushel FM; Hänninen O
    Toxicol Appl Pharmacol; 1996 Oct; 140(2):364-9. PubMed ID: 8887453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The inhibition and protection of cholinesterase by physostigmine and pyridostigmine against Soman poisoning in vivo.
    Xia DY; Wang LX; Pei SQ
    Fundam Appl Toxicol; 1981; 1(2):217-21. PubMed ID: 7184786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of carboxylesterase inhibition on carbamate protection against soman toxicity.
    Maxwell DM; Brecht KM; Lenz DE; O'Neill BL
    J Pharmacol Exp Ther; 1988 Sep; 246(3):986-91. PubMed ID: 3418520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acetylcholinesterase inhibition by (+)physostigmine and efficacy against lethality induced by soman.
    Harris LW; Anderson DR; Pastelak AM; Vanderpool B
    Drug Chem Toxicol; 1990; 13(2-3):241-8. PubMed ID: 2276342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous administration of low dose rates of physostigmine and hyoscine to guinea-pigs prevents the toxicity and reduces the incapacitation produced by soman poisoning.
    Wetherell JR
    J Pharm Pharmacol; 1994 Dec; 46(12):1023-8. PubMed ID: 7714714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Huperzine A as a pretreatment candidate drug against nerve agent toxicity.
    Grunwald J; Raveh L; Doctor BP; Ashani Y
    Life Sci; 1994; 54(14):991-7. PubMed ID: 8139389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subchronic physostigmine pretreatment in guinea pigs: effective against soman and without side effects.
    Philippens IH; Busker RW; Wolthuis OL; Olivier B; Bruijnzeel PL; Melchers BP
    Pharmacol Biochem Behav; 1998 Apr; 59(4):1061-7. PubMed ID: 9586868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.